SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Accel Liquid Gels – ‘CORRESP’ from 3/23/23

On:  Thursday, 3/23/23, at 3:13pm ET   ·   Delayed-Release:  Filing  –  Release Delayed   ·   Accession #:  1185185-23-247

Previous ‘CORRESP’:  ‘CORRESP’ on 9/17/21   ·   Latest ‘CORRESP’:  This Filing

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/23/23  Accel Liquid Gels                 CORRESP1/08/24    1:37K                                    Federal Filings, LLC/FA

Comment-Response or Other Letter to the SEC   —   Delayed-Release

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: CORRESP     Comment-Response or Other Letter to the SEC         HTML      8K 


This is an HTML Document rendered as filed.  [ Alternative Formats ]



  accelliq20230321_corresp.htm  
 C:  <>  <> 

accel_logo1.jpg

 

United States Securities and Exchange Commission
Washington, D.C. 20549

Division of Corporation Finance
Office of Manufacturing

 

March 20, 2023

 

RE:     Accel Liquid Gels, Inc.
 

Form 10-K for the Fiscal Year Ended May 31, 2022

Filed September 13, 2022

File No. 333-258166

 

Dear Office of Manufacturing:

 

I am Keith N. Hamilton, independent counsel representing Accel Liquid Gels, Inc. (“Accel”). This letter on its behalf is in direct response to your March 6, 2023 letter asking for responses to comments raised in that letter, and Accel provides the following response:

 

Form 10-K for the Fiscal Year Ended May 31, 2022

 

General

 

 

 

1.

Accel’s auditors are finished reviewing the 10-Qs for August 31, 2022 and November 30, 2022 and will be sending those out shortly.

 

Report of Independent Registered Public Accounting Firm, page 18

 

 

2.

The filing will be amended to include the audit report of other auditors for the fiscal year end May 31, 2021.

 

Notes to the Financial Statements
Note 2. Basis of Presentation and Summary of Significant Accounting Policies
Related Parties, page 28.

 

 

3.

The disclosure in Note 2 to the Financial Statements characterizing the $101,938 as a loan payment from Accel to its Chief Executive Officer was in error. The $101,938 was a return of capital initially made to the Company by the CEO. This error will be corrected and will reflect the correct classification of the disposition of the $101,938. The disclosure in Note 2 to the Financial Statements will be addressed with an amended 10K (10K/A) being filed by the Company.

 

On behalf of the Company, thank you for bringing the above concerns to its attention, as its goal is always to provide your office with accurate and adequate disclosures and reporting.  Please do not hesitate to contact me on the Company’s behalf should you require any further information or assistance.

 

Respectfully,

sig1.jpg

 

Keith N. Hamilton

 

Accel Liquid Gels, Inc., 5308 Cygnus Hill Cove, Salt Lake City Utah 84081
Phone: (801) 518-9500 / Email: info@accelliquidgels.com
Website: www.AccelLiquidGels.com

 

 

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘CORRESP’ Filing    Date    Other Filings
Filed on:3/23/23
3/20/23
3/6/23UPLOAD
11/30/22
9/13/2210-K
8/31/22NT 10-Q
5/31/2210-K,  NT 10-K
5/31/21
 List all Filings 
Top
Filing Submission 0001185185-23-000247   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., May 1, 11:34:19.1am ET